Cadila Pharmaceuticals appoints Anand Shetty as CEO – Emerging Markets

Prior to joining Cadila, Shetty spent more than 23 years at Novo Nordisk, holding senior leadership roles across Singapore, Indonesia, Bangladesh, and India

Cadila Pharmaceuticals Limited has appointed Anand Shetty as CEO – Emerging Markets, overseeing operations across India, Russia, Africa, and Southeast Asia. With over three decades of pharmaceutical industry experience, Shetty brings deep expertise in commercial operations, business leadership, and strategic market expansion.

Prior to joining Cadila, Shetty spent more than 23 years at Novo Nordisk, holding senior leadership roles across Singapore, Indonesia, Bangladesh, and India—including Vice President & General Manager, Managing Director, and Sales Director. Earlier in his career, he drove business development and sales leadership in key roles at RPG Life Sciences Ltd. and Ranbaxy.